Navigation Links
New Genetic Test Helps Athletes Maximize Performance, Identify Undiagnosed Risk Factors

RICHMOND, Va., April 27, 2011 /PRNewswire/ -- It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.  It can even save a life. American International Biotechnology Services (AIBioTech) today announced the launch of Sports X Factor, a test kit that provides athletes and parents of young sports competitors a wealth of information about their athletic strengths, potential health hazards and guidance for workout programs that are tailored to maximize performance.

The $200 test, which is available to the general public at, enables individuals to understand how to maximize strength, power, and endurance.  Even more important, the test can identify the length of time an athlete needs to rest after experiencing a concussion, his or her chances for negative results including cardiac risk factors and various other hazards. Sports X Factor identifies increased risks of developing health conditions such as the kind of undiagnosed heart conditions that have felled young athletes during or immediately after strenuous workouts or competitions.  Various options available with the test equip users to make better decisions about their exercise routines and to order customized workout programs based on their genetic results.

"While all the genes in this kit have been studied in the past, these tests have not been widely available to the public primarily because of cost," said Bill Miller, CEO of AIBioTech.  "We have found an accurate and affordable way to make these tests available to athletes of all ages so they can maximize their potential while greatly reducing the risk of injury and even death."

With spring sports getting underway and summer athletics around the corner, the test is especially beneficial if applied to children.  As parents and kids embark on competitive sports, the results could shape decisions parents, coaches and trainers make about which sports are most appropriate for each specific child, the best methods of training and the potential for injury or life threatening conditions.  Miller referred to this as "…understanding the athlete from the inside out."  

AIBioTech developed the test after two years of analysis of genetic information gleaned from several Genetic research projects.  The company's goal was to create a simple diagnostic tool that parents and athletes could use to make informed decisions about participation in sports.  The recent sudden deaths of several gifted young athletes compelled the company's decision to bring the product to market at this time.

About AIBioTech

AIBioTech provides the next generation in DNA based genetic testing services bringing experience derived after performing almost 20 years of research and development services in the biotechnology field. AIBioTech is one of the world's most comprehensive Contract Research Organizations, and has developed customized solutions in the field of biologics and specialty diagnostics. AIBioTech's expertise in applied genetics, molecular biology, and human genomics has led the way into the next generation of sports science with the introduction of Sports X Factor.

AIBiotech operates under CLIA, or AABB accreditations for laboratory testing subject to regulatory oversight.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Winner Baruch Blumberg, Viral Genetics Advisor, Dies at 85
2. Reportlinker Adds Cytogenetics - Technologies, Markets and Companies
3. Ambry Genetics is First Authorized Customer Service Provider in New Ion Torrent CSP Program
4. Signal Genetics and Pronto Diagnostics Announce Distribution Agreement
5. Interleukin Genetics Reports Fourth Quarter and Year End 2010 Financial Results
6. First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU
7. SG Biofuels Advances Jatropha Biotech Platform with Application of Genetic Markers to Reference Genome
8. Scientists from Toronto and Helsinki discover genetic abnormalities after creation of stem cells
9. WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
10. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
11. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... launched Rosalind™, the first-ever genomics analysis platform specifically designed for life science ... in honor of pioneering researcher Rosalind Franklin, who made a major contribution ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for any ... So which eye do you rinse first if a dangerous substance enters both eyes? It’s ... Wash with its unique dual eye piece. , “Whether its dirt and debris, or ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
Breaking Biology Technology:
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):